Protocols for Traditional Chinese Medicine guidelines for acute primary headache

Guideline registration

The guideline proposals were registered on the practice guideline registration for transparency (PREPARE) (guidelines-registry.org/), with registration number IPGRP-2021CN156.

Guideline working group

The guideline working group was founded in June 2021, with four subgroups: guideline steering committee, guideline development group (GDG), guideline secretary group, and guideline review group. The working group members are multidisciplinary experts, not only involving clinicians and methodologists but also due consideration on the values and wishes of potential conflicting parties and patients.

Guideline steering committee

The guideline steering committee comprises 10 to 15 experts. It has two chairpersons: professional and methodological chairpersons. All experts signed a conflict of interest statement, and at least one of the chairpersons did not have a conflict of interest related to this guideline. The main responsibilities of the guideline steering committee are as follows: (1) determine the topic and scope of the guideline; (2) approve the guideline proposals; (3) manage its conflict of interest statement; (4) oversee the guideline development process; (5) approve the guideline recommendation; and (6) approve the guideline publication.

Guideline development group

The GDG is composed of multidisciplinary clinical experts and methodologists. The main responsibilities of the GDG are as follows: (1) identify population, intervention, comparative measures, and outcome indicators and determine the scope of the guideline; (2) draft the guideline proposal; (3) collect and select clinical questions and outcome indicators, and construct clinical questions according to patient/population problem, intervention, comparison or control, and outcome (PICO) principles; (4) assess the importance of clinical questions and outcome indicators; (5) develop systematic reviews, evidence grading, and decision tables; (6) investigate patients’ wishes; (7) determine quality grading of evidence and reach consensus on recommendations; (8) write the full text of the guideline, complete the coordination of the external review of the guideline, and handle the external review comments; (9) document the whole process of guideline development; and (10) manage matters related to guideline development.

Guideline external review group

The external review group contains relevant experts and stakeholders, and its main task is to review the developed guideline recommendations.

Statement and management of conflict of interest

A conflict of interest statement form was made. All members of the guideline steering committee and guideline development group are required to fill in the form and agree to present the conflict of interest statement and the results of its handling as an annex to the guideline. For those who have a conflict of interest, the guideline steering committee decides whether or to what extent they would participate in the development of the guideline after discussion; those who do not have a conflict of interest could participate in the whole process.

Purpose, target population, and users of the guideline

The purpose of this guideline is to recommend TCM treatment for acute primary headache, to guide clinicians and nursing staff to standardize the use of TCM for the treatment of acute primary headache with the main purpose of pain relief, and to improve the management of patients with headache, clinical efficacy, and the quality of life of patients. Users of the guideline include physicians and nursing staff of TCM internal medicine, neurology, and other related departments. The target population of the guideline is patients who were diagnosed with acute primary headache.

Scope of the guideline

The clinical questions covered in this guideline relate to the TCM treatment of acute primary headache. The diagnosis of headache is based on the diagnostic criteria of headache disease in the Development of Internal Medicine of Traditional Chinese Medicine,^[5] which includes a class of diseases with headache as the main clinical feature caused by external factors and internal injury resulting in constriction or loss of nourishment of the veins and channels or by unfavorable clearing of the orifices. Western medicine diagnosis is based on the International Classification of Headache, Third Edition.^[6] Primary headache includes migraine, tension-type headache, trigeminal autonomic headache, and other primary headaches. This guideline does not cover secondary headaches, painful cranial neuropathy, other facial pain, or other types of headaches. This guideline applies to the pharmacological treatment of ongoing headaches and does not apply to the prevention of headaches during remission in patients with headache. Interventions include oral and topical TCM treatments.

Construction of clinical questions

The working group investigates the importance of the collected and summarized PICO clinical questions and outcome indicators after reviewing relevant guidelines and surveying clinicians, multidisciplinary experts, and patients. The survey respondents are multidisciplinary experts and patients/guardians who rate the importance of clinical questions and outcome indicators. The importance of the outcome indicator is assessed through the method recommended by the GRADE working group.^[7] The selection of clinical problems will be completed through multiple rounds of questionnaires.

Evidence retrieval

In this guideline, published relevant guidelines, systematic reviews, and related literature published domestically and internationally in the past 3 years are retrieved based on the questions covered. Evidence evaluation will be performed based on the results of systematic reviews if the evidence in existing guidelines is not sufficient to answer the clinical questions posed in this guideline; relevant literature will be retrieved by the guideline development group to produce systematic reviews if high-quality systematic reviews in the past 3 years are not retrieved. Evidence from ancient sources lacking clinical studies is retrieved by an antiquarian literature agency based on the Classification Standard of Evidence in Ancient Books of TCM,^[8] and a retrieval report will be produced. The National Library of Medicine (PubMed), the Cochrane Library, and the Cochrane CENTRAL database (The Cochrane Central Register of Controlled Trials), Guideline International Network (GIN), National Guideline Clearinghouse (NGC), National Institute for Health and Clinical Excellence (NICE), Scottish Intercollegiate Guide Network (Scottish Intercollegiate Guidelines Network, SIGN), World Health Organization (WHO) database, Wanfang, China National Knowledge Infrastructure (CNKI), China Biomedical Literature Database (SinoMed), and Chinese Sci-tech Journal Database (VIP), Baidu Xueshu (https://xueshu.baidu.com/), Yimaitong (https://www.medlive.cn/), and Zhonghua Yidian (TCM Dictionary) version 5.0 will be searched. Specific retrieval strategies are developed based on the characteristics of different databases using a combination of subject terms and free words. The development of retrieval strategies and the literature retrieval are conducted under the guidance of a literature retrieval specialist. No language limitation is applied. In addition, references from included studies are traced to gain access to relevant literature. Information such as relevant retrieval strategies and results are reported in a formal guideline document.

Evidence evaluation

The methodological quality of the included guidelines is evaluated using the GRADE approach.^[9] The evidence quality will be categorized as “high”, “moderate”, “low”, or “very low”. The evaluation process is completed independently by at least three people, and the coefficient of internal consistency among the evaluation team members is calculated. The methodological quality of the included systematic reviews re-review, systematic reviews, meta-analyses, and network meta-analyses were evaluated using the AMSTAR scale.^[10] The evaluation of the ancient evidence is completed by the guideline development group according to the TCM ancient evidence standards. The evaluation process is completed independently by two members, and if there is disagreement, it is discussed together, or a third party is consulted to resolve it. If no systematic reviews related to the clinical questions is retrieved, GDG will make a new round of systematic reviews to answer the clinical questions.

Recommendations

The guideline development group develops a “Problem-Recommendations-Evidence” decision form, sets the expert opinions as “Agree, Disagree, and Uncertain,” and submits it to the expert steering committee. The expert steering committee will reach consensus on the recommendations by telephone, email, or face-to-face method.

External review

The guideline recommendations will be submitted to the external review team for feedback, and the feedback will be reviewed by the guideline steering committee to determine and publish the final version of the recommendations of the guideline.

Implementation and dissemination of the guideline

After the guideline is reviewed and revised by the expert steering committee based on the external review, the full text of the guideline will be published in relevant journals, popular science journals, and other relevant mass media. Dissemination will be performed by holding relevant conferences and training courses.

Update of the guideline

The guideline is planned to be updated every 5 years.